In addition, the difference in the expression level of EMT markers was investigated between breast cancer stages, and we found that ZEB2 and vimentin expression was highly upregulated in the end‐stage BC patients compared with early‐stage of cancer. The gene discussed is ZEB2; the disease is breast carcinoma.